Sigurdur Oli Olafsson, Actavis’ CEO, was a speaker and panel member at the 15th annual EGA conference, of the European Generic Medicines Association, in Barcelona 3-5 June 2009.

Sigurdur discussed the future of generics in a turbulent environment, including the impact of the current world economical situation and expressed his vision on how generic players must remain competitive in current and future challenges.

The title of the conference was “Generic medicines enhancing pharmaceutical competition and ensuring healthcare sustainability”.